Medical Innovation Exchange

Geron eyes 2024 US launch for MDS drug after phase 3 trial shows easing of transfusion burden

https://www.fiercebiotech.com/biotech/geron-eyes-2024-us-launch-mds-drug-after-phase-3-trial-shows-reduction-infusion-dependence

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!